MedTrace Logo

Safety & Efficacy of the Laser Scleral Microporation Procedure (Taiwan)

NCT04151446 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2022-08-03

No results posted yet for this study

Summary

A new minimally invasive procedure for treating presbyopia is being evaluated to determine if there is improvement in near and intermediate vision after treatment.

Conditions

Interventions

DEVICE

Laser Scleral Microporation

Partial depth scleral microporations with an Er:YAG laser in a predetermined pattern.

Sponsors & Collaborators

  • Vision Renu Taiwan Corporation

    collaborator INDUSTRY

  • ACE Vision Group, Inc.

    lead INDUSTRY

Principal Investigators

  • David Ma, MD · Chang Gung Memorial Hospital

  • Arvin Sun, MD · Chang Gung Memorial Hospital, Keelung

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04151446 on ClinicalTrials.gov